Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
Rixubis PI 15 Aug 2018
Feiba-NF CMI 15 Aug 2018
Feiba-NF PI 15 Aug 2018
Zocor CMI 15 Aug 2018
Lipex CMI 15 Aug 2018

New products

Product name Type Date released
APO-Ivabradine CMI 06 Aug 2018
APO-Ivabradine PI 06 Aug 2018
Glimepiride APOTEX CMI 06 Aug 2018
Glimepiride APOTEX PI 06 Aug 2018
Ondansetron Mylan Tablets PI 03 Aug 2018